New Product Launched(Montelukast Tablets IP 10 mg,Methylprednisolone Tablets USP 4 mg)
03rd February 2026
Montelukast Tablets IP 10 mg
Montelukast Tablets IP 10 mg contains the active substance Montelukast which is a member of a class of medicines called leukotriene receptor antagonist and Montelukast act by blocking the action of natural substances in the body called leukotrienes.
Montelukast helps to reduce inflammation, making breathing easier and preventing asthma and allergy symptoms as a maintenance preventative medicine.
Methylprednisolone Tablets USP 4 mg
Methylprednisolone Tablets USP 4 mg contains the active substance Methylprednisolone is classified as a corticosteroid and more specifically a glucocorticoid. It is also categorized as an anti-inflammatory agent.
Methylprednisolone is a prescription only medication used to treat a wide variety of conditions, including: Severe allergies, Asthma and other respiratory problems, some skin problems and certain cancers.
